LUTATHERA Injection General Use Result Survey

Novartis Investigative Site, Nagoya

Novartis Investigative Site, Hirosaki

Novartis Investigative Site, Kamogawa

Novartis Investigative Site, Kashiwa

Novartis Investigative Site, Tōon

Novartis Investigative Site, Fukuoka

Novartis Investigative Site, Fukushima

Novartis Investigative Site, Gifu

Novartis Investigative Site, Maebashi

Novartis Investigative Site, Sapporo

Novartis Investigative Site, Sapporo

Novartis Investigative Site, Akashi

Novartis Investigative Site, Kobe

Novartis Investigative Site, Kanazawa

Novartis Investigative Site, Kita-gun

Novartis Investigative Site, Kagoshima

Novartis Investigative Site, Kamakura

Novartis Investigative Site, Yokohama

Novartis Investigative Site, Sendai

Novartis Investigative Site, Suwa

Novartis Investigative Site, Kurashiki

Novartis Investigative Site, Okayama

Novartis Investigative Site, Osaka

Novartis Investigative Site, Ōsaka-sayama

Novartis Investigative Site, Suita

Novartis Investigative Site, Hamamatsu

Novartis Investigative Site, Iwata

Novartis Investigative Site, Sunto Gun

Novartis Investigative Site, Bunkyo-ku

Novartis Investigative Site, Chuo Ku

Novartis Investigative Site, Koto Ku

Novartis Investigative Site, Chūō

Novartis Investigative Site, Chiba

Novartis Investigative Site, Fukui

Novartis Investigative Site, Fukuoka

Novartis Investigative Site, Hiroshima

Novartis Investigative Site, Kobe

Novartis Investigative Site, Kumamoto

Novartis Investigative Site, Kyoto

Novartis Investigative Site, Niigata

Novartis Investigative Site, Osaka

Novartis Investigative Site, Osaka

Novartis Investigative Site, Shizuoka

Novartis Investigative Site, Tokushima

Novartis Investigative Site, Toyama

Novartis Investigative Site, Yamagata